Vivos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	8	15	9	52	103	-	-
Market Cap Growth	-	61.00%	-82.13%	-49.94%	-	-	-
Enterprise Value	8	15	8	29	86	3	-1
PE Ratio	-1.10	-1.10	-0.39	-2.55	-5.75	-	-
PS Ratio	0.57	1.08	0.58	3.07	7.92	-	-
PB Ratio	19.01	36.24	1.93	2.03	6.11	-	-
P/FCF Ratio	-1.16	-1.16	-0.45	-2.86	-17.83	-	-
P/OCF Ratio	-1.25	-1.25	-0.47	-3.29	-18.21	-	-
EV/Sales Ratio	0.59	1.10	0.51	1.72	6.61	0.26	-0.16
EV/EBITDA Ratio	-1.18	-1.18	-0.35	-1.48	-7.69	-0.30	0.08
EV/EBIT Ratio	-1.12	-1.12	-0.34	-1.43	-7.23	-0.28	0.07
EV/FCF Ratio	-1.19	-1.19	-0.40	-1.60	-14.90	-0.54	0.09
Debt / Equity Ratio	4.85	4.85	0.50	0.05	0.08	-1.26	0.14
Debt / EBITDA Ratio	-0.15	-0.15	-0.10	-0.06	-0.11	-0.38	-0.09
Debt / FCF Ratio	-0.16	-0.16	-0.12	-0.07	-0.22	-0.67	-0.10
Quick Ratio	0.25	0.25	0.58	3.43	2.52	0.19	0.87
Current Ratio	0.34	0.34	0.80	3.64	2.60	0.22	0.93
Asset Turnover	1.06	1.06	0.75	0.47	0.80	1.45	-
Interest Coverage	-	-	-	-1448.14	-124.59	-77.00	-80.95
Return on Equity (ROE)	-568.60%	-568.60%	-188.70%	-74.60%	-257.50%	-1248.00%	-
Return on Assets (ROA)	-104.70%	-104.70%	-110.80%	-56.80%	-109.40%	-149.20%	-
Return on Capital (ROIC)	-718.87%	-718.87%	-346.98%	-76.04%	-66.13%	-1379.98%	-151.20%
Earnings Yield	-173.84%	-91.20%	-257.76%	-39.18%	-17.39%	-	-
FCF Yield	-163.81%	-85.93%	-221.72%	-35.02%	-5.61%	-	-
Buyback Yield / Dilution	-32.46%	-32.46%	-8.39%	-65.00%	-4.36%	-6.78%	-
Total Shareholder Return	-32.46%	-32.46%	-8.39%	-65.00%	-4.36%	-6.78%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).